D-1379-2020 Class II Terminated

Recalled by EMD Serono, Inc. — Rockland, MA

FDA drug recall D-1379-2020 was initiated by EMD Serono, Inc. on Jun 29, 2020 and is designated Class II. Reason for recall: Defective Container: Market complaints of missing rubber stoppers from drug vial. Missing rubber stoppers could lead to lack of sterility assurance. The recall status is terminated (terminated Mar 11, 2022). Affected quantity: 30,756 vials.

Recall details

Product Type
Drugs
Report Date
Jul 15, 2020
Initiation Date
Jun 29, 2020
Termination Date
Mar 11, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
30,756 vials

Product description

Cetrotide (cetrorelix acetate for Injection) 0.25 mg, Sterile - for subcutaneous use only, Rx Only, Manufactured for: EMD Serono, Inc., Rockland, MD 02370, NDC: 44087-1225-1

Reason for recall

Defective Container: Market complaints of missing rubber stoppers from drug vial. Missing rubber stoppers could lead to lack of sterility assurance.

Distribution pattern

Nationwide in the US

Code information

Lot # 8J025A; 8J025B, Exp 09/30/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1379-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1379-2020. Report a data issue: hello@regdatalab.com.